Related Experiment Videos
Acute, transient urinary retention from combined ecstasy and methamphetamine use
João H Delgado1, Michael J Caruso, Javier C Waksman
1Denver Health Medical Center, Denver, Colorado, USA.
The Journal of Emergency Medicine
|February 26, 2004
Summary
This study documents a rare case of acute urinary retention caused by combined methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) use. This adverse effect, potentially linked to alpha-adrenoceptor stimulation, highlights a less-recognized risk of these popular synthetic amphetamines.
Area of Science:
- Pharmacology
- Toxicology
- Urology
Background:
- Methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) are popular synthetic amphetamine analogs with known adverse effects.
- Physiologic effects of these drugs are well-documented, but urinary retention is rarely reported.
Observation:
- A case of acute, transient urinary retention is presented.
- The patient used a combination of MDMA and methamphetamine.
- Laboratory confirmation of drug use was obtained.
Findings:
- Urinary retention is a rare adverse effect associated with MDMA and methamphetamine.
- The mechanism is hypothesized to involve alpha-adrenoceptor stimulation at the bladder neck.
- Combined use may increase the risk of this specific adverse event.
Implications:
- Clinicians should consider urinary retention as a potential complication of MDMA and methamphetamine use.
- This finding expands the known spectrum of adverse effects for these widely used substances.
- Further research may be warranted to elucidate the precise mechanism and prevalence of this condition.